Optimizing rectal cancer management: analysis of current evidence

Dis Colon Rectum. 2014 Feb;57(2):252-9. doi: 10.1097/DCR.0000000000000020.

Authors

M A Abbas¹, G J Chang, T E Read, D A Rothenberger, J Garcia-Aguilar, W Peters, John R T Monson, A Sharma, D W Dietz, R D Madoff, J W Fleshman, F L Greene, S D Wexner, F H Remzi; Consortium for Optimizing Surgical Treatment of Rectal Cancer

Collaborators

Consortium for Optimizing Surgical Treatment of Rectal Cancer:
John R T Monson, D W Dietz, J W Fleshman, F L Greene, S D Wexner, F H Remzi, M A Abbas, G J Chang, T E Read, D A Rothenberger, J Garcia-Aguilar, W Peters, R D Madoff, N Baxter, D Beck, A Bennett, M Berho, G Chang, J Efron, A Fichera, J Goldblum, J G Guillem, M Kalady, E Kennedy, L Kosinski, D Larson, A Lowry, K A Ludwig, H M MacRae, J Merlino, P Roberts, L Rosen, B Safar, L Stocchi, M Whiteford

Affiliation

¹ Rochester, New York Rochester, New York, Manchester, United Kingdom Cleveland, Ohio Minneapolis, Minnesota Dallas, Texas Chapel Hill, North Carolina Weston, Florida Cleveland, Ohio.

PMID: 24401889
DOI: 10.1097/DCR.0000000000000020

No abstract available

MeSH terms

Combined Modality Therapy
Humans
Neoplasm Staging
Patient Care Team
Patient Selection
Quality of Health Care*
Rectal Neoplasms / pathology
Rectal Neoplasms / surgery*
Specialization